Literature DB >> 4033466

Fatty acid composition and Shwartzman activity of lipopolysaccharides from oral bacteria.

J Mashimo, M Yoshida, K Ikeuchi, S Hata, S Arata, N Kasai, K Okuda, I Takazoe.   

Abstract

The composition and the nature of the linkage of fatty acids and the Shwartzman activity of lipopolysaccharide (LPS) preparations derived from oral gram-negative bacteria including Bacteroides gingivalis, Bacteroides loesheii, Eikenella corrodens, Fusobacterium nucleatum, and Actinobacillus actinomycetemcomitans were examined. 3-Hydroxylated and nonhydroxy fatty acids of various chain lengths were found in all of the LPS preparations. All nonhydroxy fatty acids were found to be ester-bound, and part of the 3-hydroxy fatty acids in the LPS of B. gingivalis, E. corrodens, F. nucleatum, and A. actinomycetemcomitans were shown to be involved in ester linkage. It was also suggested that the hydroxy group of the ester-bound 3-hydroxy fatty acid of the LPS of F. nucleatum and A. actinomycetemcomitans is at least partly substituted by another fatty acid, but in the LPS of B. gingivalis and E. corrodens it is not. The main amide-linked fatty acid of the LPS of B. gingivalis, E. corrodens, F. nucleatum, and A. actinomycetemcomitans was 3-hydroxyheptadecanoic, 3-hydroxydodecanoic, 3-hydroxyhexadecanoic, and 3-hydroxytetradecanoic acid, respectively. The results of the Shwartzman assay showed that the E. corrodens LPS was the most active among the preparations tested, and that the Shwartzman toxicity of Bacteroides LPS is extremely low.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4033466     DOI: 10.1111/j.1348-0421.1985.tb00840.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Precipitating antibody against lipopolysaccharide of Haemophilus actinomycetemcomitans in human serum.

Authors:  K Okuda; T Kato; Y Naito; I Takazoe
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

2.  Antigenic characteristics and serological identification of 10 black-pigmented Bacteroides species.

Authors:  K Okuda; K Ohta; T Kato; I Takazoe; J Slots
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

3.  Protection of mice against the lethal toxicity of a lipopolysaccharide (LPS) by immunization with anti-idiotype antibody to a monoclonal antibody to lipid A from Eikenella corrodens LPS.

Authors:  T Kato; I Takazoe; K Okuda
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 4.  Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis.

Authors:  Sumita Jain; Richard P Darveau
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

5.  Relationship between hydroxy fatty acids and prostaglandin E2 in gingival tissue.

Authors:  F Nichols; B Maraj
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Hemagglutinating activity of lipopolysaccharides from subgingival plaque bacteria.

Authors:  K Okuda; T Kato
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

7.  Detection of specific antibody in adult human periodontitis sera to surface antigens of Bacteroides gingivalis.

Authors:  Y Naito; K Okuda; I Takazoe
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

8.  Prostaglandin E release from human monocytes treated with lipopolysaccharides isolated from Bacteroides intermedius and Salmonella typhimurium: potentiation by gamma interferon.

Authors:  F C Nichols; J F Peluso; P J Tempro; S W Garrison; J B Payne
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Structural analysis of lipopolysaccharides from Eikenella corrodens by use of murine monoclonal antibodies.

Authors:  T Kato; I Takazoe; K Okuda
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Distribution of 3-hydroxy iC17:0 in subgingival plaque and gingival tissue samples: relationship to adult periodontitis.

Authors:  F C Nichols
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.